Clinical Trial Update: 48 Hours Esophagal pH-monitoring With and Without Gaviscon [NA]

View source ↗

Summary

This completed clinical trial compared 48-hour esophageal pH monitoring with and without Gaviscon in patients with gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Gaviscon

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Gastroesophageal Reflux | NA | Status: COMPLETED